News and Stories About precision medicine
Pancreatic Cancer Researchers, Clinicians ‘Unlock Superpowers’ at Annual Scientific Summit
The fitting theme for this year’s Pancreatic Cancer Action Network (PanCAN) Annual Scientific Summit, occurring Aug. 23-26, 2018, in San […]
READ MORE
Precision Medicine Highlighted in the News
“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE
Forbes Article Discusses Potential of PARP Inhibitors to Treat Certain Pancreatic Cancer Patients
The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE
Pancreatic Cancer Action Network invests in Precision Medicine and Early Detection
Pancreatic Cancer Action Network invests in precision medicine and early detection to change outcomes for the world’s toughest cancer MANHATTAN […]
READ MORE
5 Things to Know About New Drug Keytruda
Editor’s note: At the American Association for Cancer Research (AACR) Annual Meeting on April 16, 2018, results of a clinical […]
READ MORE
Recent Precision Medicine Developments Showing Promise of Field
May was a busy month for pancreatic cancer precision medicine developments. Every pancreatic tumor is different. The Pancreatic Cancer Action […]
READ MORE
Know Your Tumor® Gives Survivor More Options, Time to Experience More Blessings
Josephine Scivoli’s oncologist tells her she’s an inspiration, a miracle. Her husband, John, agrees. “She definitely has a lot of […]
READ MORE
Results of Large-scale Molecular Profiling Effort Are Published, Shared
The American Association for Cancer Research (AACR) is spearheading a large-scale molecular profiling effort called Project Genomics Evidence Neoplasia Information […]
READ MORE
The Road to Effective Immunotherapy for Pancreatic Cancer Patients
Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE
Unprecedented Drug Approval Can Benefit Pancreatic Cancer Patients
For the first time, the U.S. Food and Drug Administration (FDA) has approved a cancer drug based only on molecular […]
READ MORE
Rare but Targetable Genetic Change Discovered in Pancreatic Cancer Patients
The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE
Revolutionary Clinical Trial Initiative Focuses On Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients
Revolutionary Clinical Trial Initiative Focuses On Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients […]
READ MORE
Leading Oncologist Champions Treatment Progress Through Personalized Medicine
Dr. Andrew E. Hendifar, the medical oncology lead for the gastrointestinal disease research group at Cedars-Sinai Medical Center, champions progress […]
READ MORE
Study Shows Biomarker-Based Treatment Provides Best Results
We’ve learned a lot about pancreatic cancer in recent years, and we now know that every patient’s cancer is different […]
READ MORE
